Alzheimer Disease: Clinical Trials

3,874 trials for Alzheimer Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2100 completed, 546 recruiting, 448 unknown, 292 terminated. 1388 Not applicable, 713 Phase 2, 557 Phase 1, 346 Phase 3, 136 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1388Completed 720, Recruiting 212, Unknown 196, Not yet recruiting 83, Terminated 62, Active not recruiting 50, Withdrawn 39, Enrolling by invitation 22, Suspended 4
Phase 2713Completed 412, Terminated 84, Recruiting 75, Unknown 61, Active not recruiting 31, Not yet recruiting 23, Withdrawn 20, Enrolling by invitation 7
Phase 1557Completed 385, Terminated 49, Recruiting 44, Unknown 32, Not yet recruiting 19, Active not recruiting 17, Withdrawn 10, Suspended 1
Phase 3346Completed 193, Terminated 65, Recruiting 36, Unknown 19, Active not recruiting 17, Not yet recruiting 9, Withdrawn 6, Suspended 1
Phase 4136Completed 86, Unknown 17, Recruiting 10, Terminated 8, Withdrawn 5, Active not recruiting 4, Not yet recruiting 4, Enrolling by invitation 2
Early Phase 163Completed 36, Recruiting 9, Terminated 8, Active not recruiting 4, Not yet recruiting 2, Unknown 2, Enrolling by invitation 1, Withdrawn 1

Follow Alzheimer Disease: new trials by email Literature Review of Alzheimer Disease trials Research Report on Alzheimer Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tau Pathology in the Brain After Hip or Knee Replacement Surgery
Hip or Knee Arthroplasty Under Spinal Anesthesia - Postoperative Cognitive Dysfunction, Alzheimer Disease
RecruitingUppsala University Hospital302029-04-012026-10-15
Smartphone App for Adolescents With Idiopathic Scoliosis
DinSkoliose smartphone application - Adolescence Idiopathic Scoliosis, AIS
Not applicableNot yet recruitingOslo Metropolitan University302028-04-012026-07-07
Transcranial Magnetic Stimulation for Alzheimer's Disease Treatment
Active Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation - Alzheimer Disease
Not applicableNot yet recruitingUniversitat Oberta de Catalunya452027-11-012026-07-21
AV-1959R Vaccine in Individuals With Preclinical Alzheimer's Disease
AV-1959R, Placebo - Preclinical Alzheimer's Disease, Alzheimer Disease
Phase 2Not yet recruitingInstitute for Molecular Medicine1602027-10-012026-10-21
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Neuronavigation-guided single-element focused ultrasound transducer, Lumason, Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents - Alzheimer Disease, Early Onset
Phase 1Not yet recruitingColumbia University62027-08-012026-05-13
Terazosin And Metabolic Engagement in Alzheimer's Disease
Terazosin (Hytrin), Placebo - Alzheimer s Disease
Phase 2Not yet recruitingQiang Zhang1002027-08-012026-09-01
GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)
GV1001 Placebo, GV1001 1.12mg - Moderate to Severe Alzheimer's Disease
Phase 3Not yet recruitingSamsung Pharmaceutical Co., Ltd.7502027-07-012026-06-10
Advancing Ethical Goals In Society Trial
ACP Counselor Video Program - Advance Care Planning, Dementia
Not applicableNot yet recruitingTufts Medical Center121742027-03-012026-09-17
Vagus Nerve Stimulation to Enhance Memory in Aging
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) - Alzheimer Disease, Aging
Not applicableNot yet recruitingStanford University1502027-02-012025-10-09
HomeCare Medication Management for People With Dementia
HomeCare - Dementia, Alzheimer's Disease and Related Dementias
Not applicableNot yet recruitingHiDO Technologies1202027-01-012026-10-13
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Comfy Acupressure for the Elderly, Least acupressure control - Alzheimer's Disease
Not applicableNot yet recruitingThe University of Hong Kong1882027-01-012026-08-24
Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease
Emtricitabine and tenofovir disoproxil fumarate combination, Placebo - Alzheimer's Disease
Phase 1Not yet recruitingBrigham and Women's Hospital202026-12-012026-08-31
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
Brain Stimulation - Alzheimer&Amp;#39;s Disease-related Dementia, Alzheimer Disease
Not applicableNot yet recruitingBaylor College of Medicine202026-12-012026-10-05
Improv Music Therapy for Older Adults
Clinical Improvisation - Alzheimer's Disease (AD), Older Adults (65 Years and Older)
Not applicableNot yet recruitingUniversity of California, San Francisco402026-12-012026-02-23
Aging and Exercise Impacts on Glymphatic Function
Acute Aerobic exercise - Aging and Exercise Impacts on Glymphatic Function
Not applicableNot yet recruitingUniversity of Texas Southwestern Medical Center2402026-12-012026-10-05
High-Velocity Resistance Training for Brain Blood Flow and Cognitive Function in Older Adults
High-Velocity Resistance Training - At Risk for AD-dementia, With Subjective Cognitive Decline, At Risk for Cognitive Decline
Not applicableNot yet recruitingUniversity of Illinois at Chicago602026-12-012026-10-14
Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study
Tricaprilin, Placebo - Alzheimer Disease
Phase 3Not yet recruitingCerecin5352026-12-012026-07-01
Electroconvulsive Therapy for Treatment of Alzheimer´s Disease
Thymatron IV device (Somatics) - Alzheimer's Disease
Not applicableNot yet recruitingCentral Institute of Mental Health, Mannheim152026-12-012026-09-08
SmartEnLite for Nursing Home Residents With Dementia
Smart Environmental Light (SmartEnLite) - Alzheimer's Disease and Related Dementias, Alzheimer Disease and Related Dementias
Not applicableNot yet recruitingPenn State University3002026-12-012026-10-20
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Trontinemab, Placebo - Alzheimer's Disease
Phase 3RecruitingHoffmann-La Roche16002026-11-302026-10-13

Showing 20 of 3874. Sign in to see all of them.

Narrower conditions

Dementia (940)  ·  Cognitive Dysfunction (837)  ·  Neurodegenerative Diseases (128)  ·  Parkinson Disease (126)  ·  Memory Disorders (121)  ·  Dementia, Vascular (116)  ·  Lewy Body Disease (108)  ·  Frontotemporal Dementia (91)  ·  Depression (88)  ·  Brain Diseases (82)  ·  Caregiver Burden (80)  ·  Motor Activity (72)  ·  Neurocognitive Disorders (72)  ·  Plaque, Amyloid (72)

Broader conditions

Tauopathies (3820)  ·  Central Nervous System Diseases (3811)  ·  Nervous System Diseases (3811)  ·  Mental Disorders (3803)  ·  Neurocognitive Disorders (3802)  ·  Brain Diseases (3792)  ·  Neurodegenerative Diseases (3746)  ·  Dementia (2934)  ·  Cognition Disorders (837)  ·  Pathological Conditions, Signs and Symptoms (662)  ·  Signs and Symptoms (439)  ·  Neurologic Manifestations (421)  ·  Behavior (383)  ·  Neurobehavioral Manifestations (311)  ·  Nutritional and Metabolic Diseases (248)

Interventions

Donepezil (123)  ·  florbetapir (53)  ·  Memantine (47)  ·  Transcranial Direct Current Stimulation (44)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (41)  ·  Galantamine (38)  ·  Exercise (35)  ·  Magnetic Resonance Spectroscopy (33)  ·  Blood Specimen Collection (32)  ·  Transcranial Magnetic Stimulation (29)  ·  Rivastigmine (28)  ·  4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (26)  ·  Cognitive Training (23)  ·  2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (20)  ·  latrepirdine (20)

Sponsors

Pfizer (62)  ·  Eli Lilly and Company (57)  ·  Avid Radiopharmaceuticals (42)  ·  National Institute on Aging (NIA) (42)  ·  Indiana University (32)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (32)  ·  GlaxoSmithKline (31)  ·  Merck Sharp & Dohme LLC (31)  ·  Assistance Publique - Hôpitaux de Paris (28)  ·  Johns Hopkins University (28)  ·  Massachusetts General Hospital (28)  ·  Chang Gung Memorial Hospital (27)  ·  Emory University (27)  ·  Hoffmann-La Roche (27)  ·  Centre Hospitalier Universitaire de Nice (26)

Countries

United States (1902)  ·  France (429)  ·  Canada (307)  ·  Spain (267)  ·  United Kingdom (246)  ·  China (238)  ·  Germany (202)  ·  Italy (199)  ·  Australia (169)  ·  South Korea (168)  ·  Japan (132)  ·  Netherlands (132)  ·  Sweden (127)  ·  Poland (106)  ·  Taiwan (103)

Top investigators

Danna Jennings, MD (16)  ·  Paul Aisen, MD (12)

Results publications

PMID 39498781, PMID 33189083, PMID 40603145, PMID 39800465, PMID 34815790, PMID 40049590, PMID 25918556, PMID 26120369, PMID 26402769, PMID 33417236, PMID 33974419, PMID 39324520, PMID 40667684, PMID 40681915, PMID 41533472, PMID 41804324, PMID 41961243, PMID 27807285, PMID 27871675, PMID 29318278, PMID 30474567, PMID 31193334, PMID 31969177, PMID 33773598, PMID 34532852, PMID 36627206, PMID 36641609, PMID 36934371, PMID 36946603, PMID 37996817, PMID 39108660, PMID 39350369, PMID 39513754, PMID 39556389, PMID 41220869, PMID 41537338, PMID 41591746, PMID 42552749, PMID 42841310, PMID 15817019, PMID 18854539, PMID 20921879, PMID 21371747, PMID 22749065, PMID 22784036, PMID 24345389, PMID 24450890, PMID 24450891, PMID 25022541, PMID 25125457

NIH funding

2023 (18), 2009 (17), 2016 (15), 2015 (14), 2017 (14), 2025 (14), 2014 (12), 2018 (11), U54AG063546 (8), 2019 (6), U01AG010483 (6), P30AG024978 (5), U01AG059798 (5), 1RC2AG036535 (4), R01AG046179 (4)